Lawrence W. Elmer

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

Reed Johnson, C. Singer, Reed Johnson, 2018, CNS Drugs.